Patents by Inventor Michael G. Schmidt
Michael G. Schmidt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7732197Abstract: The present invention relates to multi-ribozymes and their use to target RNA in a tissue-specific, target RNA-specific, or pathogen-specific manner for the treatment of cancers, proliferative disease, and bacterial, parasitic and viral infections. More specifically, the present invention relates to the use of virions and viral vectors to package and deliver DNA encoding the multi-ribozymes to a host. The present invention relates to the use of liposomes and lipid-DNA complexes to deliver DNA encoding ribozymes to a host. Most specifically, the invention relates to the use of target specific virions to package and deliver DNA comprising a target specific promoter and encoding a ribozyme(s) directed to the target organism nucleic acids. The present invention further relates to a novel vectors encoding a multi-ribozyme structure with enhanced 5? and/or 3? autocatalytically cleaving ribozymes.Type: GrantFiled: February 26, 2002Date of Patent: June 8, 2010Assignees: The Penn State Research Foundation, MUSC Foundation for Research DevelopmentInventors: James S. Norris, Gary A. Clawson, Michael G. Schmidt, Brian Hoel, Wei-Hua Pan, Joseph W. Dolan
-
Patent number: 7575918Abstract: The present invention relates to the discovery, identification and characterization of toxic agents which are lethal to pathogens and methods for targeting such toxic agents to a pathogen or pathogen infected cells in order to treat and/or eradicate the infection. In particular, the present invention relates to toxic agents which target bacteria at different stages of the bacterial life cycle, which are delivered alone or in combination to bacteria or bacteria-infected cells. The invention relates to toxic agents which are lethal to diseased cells and methods for targeting such toxic agents to a diseased cell in order to treat and/or eradicate the disease. The present invention relates to promoter elements which are pathogen-specific or tissue-specific and the use of such promoter elements to achieve pathogen-specific or tissue-specific expression of the toxic agent(s) and/or ribozyme(s) of the present invention.Type: GrantFiled: September 8, 2004Date of Patent: August 18, 2009Assignee: The Penn State Research FoundationInventors: James Norris, Gary Clawson, Caroline Westwater, David Schofield, Michael G. Schmidt, Brian Hoel, Joseph Dolan, Wei-Hua Pan
-
Publication number: 20040220123Abstract: The present invention relates to the discovery, identification and characterization of toxic agents which are lethal to pathogens and methods for targeting such toxic agents to a pathogen or pathogen infected cells in order to treat and/or eradicate the infection. In particular, the present invention relates to toxic agents which target bacteria at different stages of the bacterial life cycle, which are delivered alone or in combination to bacteria or bacteria-infected cells. The invention relates to toxic agents which are lethal to diseased cells and methods for targeting such toxic agent to a diseased cell in order to treat and/or eradicate the disease. The present invention relates to promoter elements which are pathogen-specific or tissue-specific and the use of such promoter elements to achieve pathogen-specific or tissue-specific expression of the toxic agent(s) and/or ribozyme(s) of the present invention.Type: ApplicationFiled: May 27, 2003Publication date: November 4, 2004Inventors: James S. Norris, Caroline Westwater, David A. Schofield, Michael G. Schmidt, Brian D. Hoel, Joseph W. Dolan, Gary A. Clawson, Wei-Hua Pan
-
Publication number: 20030125280Abstract: The invention provides compositions comprising the tissue specific and target RNA-specific ribozyme(s) in either a viral delivery system or a biologic liposome preparation, wherein the viral delivery system or a biologic liposome comprises a pathogen-specific promotor upstream from a sequence encoding a triple ribozyme comprising a) a 5′ autocatalytically cleaving ribozyme sequence, b) a catalytic ribozyme comprising a target RNA-specific binding site and c) a 3′ autocatalytically cleaving ribozyme sequence. The invention also provides methods of treating and/or preventing bacterial infections by administering the compositions of the invention.Type: ApplicationFiled: April 19, 2002Publication date: July 3, 2003Applicants: Medical University of South Carolina, The Penn State Research Foundation, a Pennsylvania corporationInventors: James S. Norris, Michael G. Schmidt, Joseph W. Dolan, Steven D. London, Harold D. May, Gary A. Clawson
-
Publication number: 20030092651Abstract: The present invention relates to multi-ribozymes and their use to target RNA in a tissue-specific, target RNA-specific, or pathogen-specific manner for the treatment of cancers, proliferative disease, and bacterial, parasitic and viral infections. More specifically, the present invention relates to the use of virions and viral vectors to package and deliver DNA encoding the multi-ribozymes to a host. The present invention relates to the use of liposomes and lipid-DNA complexes to deliver DNA encoding ribozymes to a host. Most specifically, the invention relates to the use of target specific virions to package and deliver DNA comprising a target specific promoter and encoding a ribozyme(s) directed to the target organism nucleic acids. The present invention further relates to a novel vectors encoding a multi-ribozyme structure with enhanced 5′ and/or 3′ autocatalytically cleaving ribozymes.Type: ApplicationFiled: February 26, 2002Publication date: May 15, 2003Applicant: Medical University of South Carolina, an agency of the State of South CarolinaInventors: James S. Norris, Gary A. Clawson, Michael G. Schmidt, Brian Hoel, Wei-Hua Pan, Joseph W. Dolan, David Schofield, Caroline Westwater, Cancan Huang
-
Patent number: 6014994Abstract: The operation of filling plants for filling drinks or other foods is subject to stringent regulations under the law on foodstuffs. In this connection, an essential aspect is the cleanness of the filling plant, which consists of a filler and a conveyor. To clean a filling plant, it is known to provide four separate cleaning systems with four separate supply stations and control systems as well as line systems.The invention provides, for all partial cleaning systems in a common central cleaning circuit (40a, 57), a common supply station (10) comprising the componentsfresh water container (12)storage containers (13-16)heating station (29)dosing station (27),which can selectively be connected to or disconnected from the cleaning circuit by means of valves and rotary valve flaps, as well as a programme control system (11) as well as a common partial line system.Type: GrantFiled: September 14, 1998Date of Patent: January 18, 2000Assignee: DiverseyLever, Inc.Inventor: Michael G. Schmidt
-
Patent number: 5957143Abstract: In the case of a process for the mechanical cleaning of reusable drinks containers made of glass or plastic, the process comprising one or more washing cycles or zones and rinsing cycles or zones in a cleaning installation, the reusable drinks containers undergo pretreatment before being supplied to the actual cleaning installation. The reusable drinks containers are sprayed with an aqueous cleaning formulation by means of one or more nozzles which produce a spray yet which is directed into the interior of the reusable containers and, in the interior of the reusable containers, is transformed into a spray mist, with the result that the cleaning formulation is distributed uniformly. The pretreatment ensures that even stubborn dirt or microorganisms such as mold or yeasts is/are removed effectively in the cleaning installation.Type: GrantFiled: October 17, 1997Date of Patent: September 28, 1999Assignee: Diversey Lever, Inc.Inventor: Michael G. Schmidt
-
Patent number: 5885828Abstract: An isolated nucleic acid encoding a SecA protein of M. tuberculosis is provided. This nucleic acid can be a native coding sequence for the SecA protein of M. tuberculosis. A specific example of the isolated nucleic acid is one that encodes a polypeptide comprising the amino acid sequence set forth in SEQ ID NO:2. An isolated fragment of the secA gene that is specific for M. tuberculosis is provided. A purified SecA protein of Mycobacterium tuberculosis is provided. The purified SecA protein of Mycobacterium tuberculosis comprises the polypeptide having the sequence set forth in the Sequence Listing as SEQ ID NO:2. Fragments of the M. tuberculosis SecA protein are provided. A purified mutant SecA protein of Mycobacterium tuberculosis is provided. The invention provides purified mutant M. tuberculosis expressing the mutant SecA protein of the invention. The invention also provides methods of screening for putative M. tuberculosis virulence factors translocated by the SecA protein.Type: GrantFiled: February 14, 1997Date of Patent: March 23, 1999Assignee: The United States of America as represented by the Department of Health and Human ServicesInventors: Frederick D. Quinn, Marie U. Owens, C. Harold King, Michael G. Schmidt